4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-004153
Chief Operating Officer sold 6,018 shares at an average $3.55 ($21,376)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bertrand William C JR Chief Operating Officer | 2022-01-11 | Sale | −3,770 | $3.56 | $13,409 | 6,343 | D |
| Bertrand William C JR Chief Operating Officer | 2022-01-12 | Sale | −2,248 | $3.54 | $7,967 | 3,754 | D |
| Open-market sales · 6,018 sh · avg $3.55 · $21,376 | |||||||
Loading xslF345X03/tm221700-14_4seq1.xml…